QuidelOrtho Corp (QDEL) Stock
4 members of Congress disclosed 9 trades in QDEL since 2020: 2 purchases and 7 sales, most recently Daniel Goldman (sale, Jul 12, 2023). 4 of the hedge funds AlphaScala tracks reported QDEL in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Millennium Management's at $12.65M.
Which members of Congress traded QuidelOrtho Corp (QDEL)?
Most recent: Daniel Goldman (sale, Jul 12, 2023); records start Mar 2, 2020.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Dan Goldman D-NY · House | 2023-07-12 | sale | $1k – $15k |
| Tom Malinowski D-NJ · House | 2021-05-11 | purchase | $15k – $50k |
| Tom Malinowski D-NJ · House | 2021-04-27 | sale | $1k – $15k |
| Tom Malinowski D-NJ · House | 2021-03-14 | sale | $1k – $15k |
| Tom Malinowski D-NJ · House | 2021-03-03 | sale | $15k – $50k |
| Tom Malinowski D-NJ · House | 2021-02-23 | sale | $15k – $50k |
| Josh Gottheimer D-NJ · House | 2020-11-11 | sale | $1k – $15k |
| Gil Cisneros D-CA · House | 2020-07-13 | sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026.
See all QDEL political trades →Which hedge funds own QDEL?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Millennium Management Israel Englander | 722K | $12.65M | +156% |
| D.E. Shaw David Shaw | 270K | $4.73M | -2% |
| Marshall Wace | 173K | $3.02M | +31% |
| Point72 Steve Cohen | 30K | $532.8K | -96% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →QDEL price chart
Powered by TradingViewWhat does QuidelOrtho Corp do?
QuidelOrtho Corporation is a leading manufacturer and provider of diagnostic testing solutions that serve the healthcare industry on a global scale. The company focuses on developing innovative diagnostic products designed to detect and diagnose a variety of medical conditions with increased accuracy and efficiency. QuidelOrtho's portfolio includes rapid diagnostic tests, traditional laboratory assays, and immunoassays that are used in clinical laboratories, hospitals, and primary care environments. The key feature of QuidelOrtho's offerings lies in its emphasis on providing reliable and timely diagnosis, which helps healthcare professionals in making informed decisions for patient care. Products from QuidelOrtho cover a broad spectrum of medical areas, including infectious diseases, cardiology, women’s health, and gastrointestinal conditions, significantly impacting public health outcomes. In the financial market, QuidelOrtho Corporation plays a crucial role in the healthcare sector, especially during times of heightened health crises. The company's commitment to advancing diagnostic technologies underscores its relevance amidst rising demand for rapid and accurate testing solutions in the medical field globally.